Case details

Print
Merger control
Case reference
Ccent/2023/68 - Grupo Insud Pharma / Women Healthcare Business
Acquired
Assets Viatris Inc.
Description
Women Healthcare Business is part of a new entity resulting from the spin-off of a Viatris group company and a set of assets and rights to commercialize Women Healthcare Business products on a global scale. They are active in the production and marketing of pharmaceutical products, medicines for human use, in particular, oral and injectable contraceptives.
Acquiring
Chemo Project S.A.
Description
Entity of the Insud Pharma Group. The Insud Pharma Group operates across the pharmaceutical value chain in various active pharmaceutical ingredients, finished dosed medicines, branded medicines for human and animal care and biopharmaceutical products. In Portugal, the Insud Pharma Group operates through a subsidiary called Exeltis Portugal, Lda.
Acquiring
Insud Pharma S.L.
Description
Entity of the Insud Pharma Group. The Insud Pharma Group operates across the pharmaceutical value chain in various active pharmaceutical ingredients, finished dosed medicines, branded medicines for human and animal care and biopharmaceutical products. In Portugal, the Insud Pharma Group operates through a subsidiary called Exeltis Portugal, Lda.
Sector
  • Health & Pharmaceutical
Activity (NACE)
Applicable legislation
Art. 37(1)(a) (Law 19)
Notification thresholds
Market Share threshold
Type of merger
Horizontal
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

This notification concerns the acquisition by the Insud Pharma Group, through Insud Pharma S.L. and Chemo Project S.A., (“Insud Pharma Group”), of exclusive control over the Women's Healthcare Business of the Viatris Group (“Women Healthcare Business ”).

Timeline
Click here to see your activities